HIV, opportunistic and transplant infection
Define the immune deficit and the disease
HIV, neutropenia, cellular therapies and solid-organ transplantation create different patterns of risk. The depth, duration and mechanism of immune dysfunction matter, as do preventive medicines and previous infection. A classic post-transplant timeline can organize a differential but is not an exact clock that excludes disease outside one interval. Fever, pulmonary lesions, diarrhea, neurological change and cytopenias can arise from infection, rejection, drugs or other processes. A positive blood viral load is not automatically equivalent to tissue-invasive disease at every anatomical site.
HIV treatment and prevention have distinct tasks
HIV diagnosis uses a validated algorithm, with appropriate follow-up of discordant or early results. Antiretroviral selection considers resistance, interactions, organ function, pregnancy and coinfections. Early treatment benefits most eligible people, but selected central nervous system opportunistic infections require a different timing assessment. Prevention of PJP, toxoplasmosis and disseminated MAC does not use one interchangeable CD4 threshold or disregard effective immediate ART. Similarly, discontinuing prophylaxis requires the actual disease, treatment and recovery conditions rather than one favorable count alone.
Recognize opportunistic syndromes
PJP assessment combines the clinical pattern with appropriate microbiological evidence; nonspecific markers cannot independently prove it. Adjunctive corticosteroids depend on the actual gas-exchange severity, not simply the presence of a ground-glass image. Cryptococcal disease assessment includes whether the CNS is involved and whether intracranial pressure needs management. An isolated positive antigen result can require further investigation before a preemptive treatment pathway is selected. Toxoplasmosis, CMV, tuberculosis and other conditions have different treatment and ART-timing considerations. Immune reconstitution can cause deterioration, but a post-ART fever is not automatically IRIS without assessing competing causes.
Neutropenia and transplantation
A febrile-neutropenia risk score only contributes to outpatient eligibility when stability, anticipated neutropenia and reliable follow-up also fit. Persistent fever can require fungal investigation and an appropriate empirical or diagnostic-driven strategy. Mold morphology, antigen results and imaging need interpretation through the actual host and test limitations. CMV donor-recipient status affects risk, while BK, EBV-related lymphoproliferation and other complications require their own assessments. Changes to immunosuppression should be coordinated with the responsible team because infection control, rejection and inflammatory rebound must be balanced. Written learning examples do not establish access to every drug or replace a monitored individualized specialist plan.